slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 7,021-7,050
Pages 467
Rows per page 30
Loop
7,021-7,050 of 13,983
12
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a molecular structure diagram to illustrate the binding site differences between CTX-471 and existing therapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a before-after-bridge style framing to highlight the drug's superior efficacy compared to standard monotherapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The slide uses a series of line charts to demonstrate efficacy across different antibody affinities.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The slide compares initial monotherapy survival against a re-challenge survival study.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The diagram shows a multi-step process involving opsonization, NK cells, macrophages, dendritic cells (DC), and T-cell activation via CD137.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a series of small-multiple line charts to show tumor growth over time and a Kaplan-Meier survival curve to show efficacy.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
The slide includes a Kaplan-Meier plot showing PFS outcomes for different patient cohorts (PD-1 refractory, immune competent).Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
Includes a pharmacokinetic simulation graph and a conceptual dose-response curve illustrating that maximal receptor occupancy may not correlate with optimal biological response.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
21
The slide presents two distinct tables: one for patient demographics/clinical history and one for cancer indications.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
22
The slide uses red arrows for primary categories and blue arrows for sub-points.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
23
Includes CT scan imagery as evidence of efficacy.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
24
Clinical trial update slide.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
25
The slide uses a flow-chart structure to segment the patient population and map them to specific therapeutic regimens across 1st line, maintenance, and 2nd line settings.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
26
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
27
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
28
The slide uses a process flow to show the transition from screening to hypothesis testing and final validation.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
29
The slide presents two distinct experimental results: a western blot for PD-1 and a line graph for CD28-His-APC binding.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
30
The slide uses a biological diagram to contrast the efficacy of standard PD-1 inhibitors versus the proprietary CTX-8371 molecule.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
31
Includes individual tumor growth curves, average tumor volume at day 15, and Kaplan-Meier survival curves.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
32
The slide uses a nested bulleted list to organize technical and strategic milestones.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
33
The slide uses a solid red background with a subtle geometric pattern in the top right corner.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
34
Shows a scientific workflow from discovery to primary and secondary screening.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
35
The slide shows dose-response curves for specific lysis of tumor cells, highlighting the potency of NKp30-based bispecifics.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
36
Includes survival curve (Kaplan-Meier) and IgM depletion bar chart.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
37
The table uses a green/red color coding to highlight the competitive advantage of the company's lead asset.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
38
The slide outlines a dual-track strategy: oncology (solid tumors) and autoimmune diseases.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
39
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
40
Uses a combination of checkmarks for completed items and stars for in-progress/future items.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
42
Evotec | Investor Day Presentation Deck | 103 slidesEvotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit